Evidence map›Paper›PMID 32322594›Full record

ArticleJournal of immunology research2020

Characterization of a Complex Mixture of Immunomodulator Peptides Obtained from Autologous Urine.

Alberto Fragoso, Mérida Pedraza-Jiménez, Laura Espinoza-González, María Luisa Ceja-Mendoza, Hugo Sánchez-Mercado, Gloria Robles-Pérez, Julio Granados, Emilio Medina-Rivero

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Alberto FragosoInstituto de Alergias y Autoinmunidad Dr. Maximiliano Ruiz Castañeda A.C., Luisa Isabel Campos #16, col. Revolución, Acambay, Edo. de México 50300, Mexico.
Mérida Pedraza-JiménezInstituto de Alergias y Autoinmunidad Dr. Maximiliano Ruiz Castañeda A.C., Luisa Isabel Campos #16, col. Revolución, Acambay, Edo. de México 50300, Mexico.
Laura Espinoza-GonzálezInstituto de Alergias y Autoinmunidad Dr. Maximiliano Ruiz Castañeda A.C., Luisa Isabel Campos #16, col. Revolución, Acambay, Edo. de México 50300, Mexico.
María Luisa Ceja-MendozaInstituto de Alergias y Autoinmunidad Dr. Maximiliano Ruiz Castañeda A.C., Luisa Isabel Campos #16, col. Revolución, Acambay, Edo. de México 50300, Mexico.
Hugo Sánchez-MercadoInstituto de Alergias y Autoinmunidad Dr. Maximiliano Ruiz Castañeda A.C., Luisa Isabel Campos #16, col. Revolución, Acambay, Edo. de México 50300, Mexico.
Gloria Robles-PérezInstituto de Alergias y Autoinmunidad Dr. Maximiliano Ruiz Castañeda A.C., Luisa Isabel Campos #16, col. Revolución, Acambay, Edo. de México 50300, Mexico.
Julio GranadosInstituto de Alergias y Autoinmunidad Dr. Maximiliano Ruiz Castañeda A.C., Luisa Isabel Campos #16, col. Revolución, Acambay, Edo. de México 50300, Mexico.ORCID https://orcid.org/0000-0001-8553-1027
Emilio Medina-RiveroUnidad de Desarrollo e Investigación en Bioprocesos (UDIBI), Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México 11340, Mexico.ORCID https://orcid.org/0000-0001-8862-1378
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXInstituto Politécnico Nacional · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A complex mixture of peptides plays a key role in the regulation of the immune system; different sources as raw materials mainly from animals and vegetables have been reported to provide these extracts. The batch-to-batch product consistency depends on in-process controls established. However, when an immunomodulator is a customized product obtained from the same volunteer who will receive the product to personalize the treatment, the criteria to establish the consistency between volunteers are different. In this sense, it is expected to have the same molecular weight range although the profile of peptide abundance is different. Here, we characterized the peptide profile of three extracts of an immunomodulator obtained from the urine of different volunteers suffering from three different diseases (i.e., allergic rhinitis, rheumatoid arthritis, and chronic rhinopharyngitis), using size exclusion chromatography (SEC) and mass spectrometry (MS). The peptides contained in the immunomodulators were stable after six months, stored in a refrigerator. Our results showed a chromatographic profile with the same range of low molecular weight (less than 17 kDa) in all analyzed samples by SEC; these results were also confirmed by MS showing an exact mass spectrum from 3 to 13 kDa. The fact that the peptide profiles were conserved during a six-month period at refrigeration conditions (2 to 8°C) maintaining the quality and stability of the immunomodulator supports the notion that it might be an alternative in the treatment of chronic hypersensibility disorders.

Indexed as

Chromatography, GelHumansImmune System DiseasesImmunologic FactorsMass SpectrometryMolecular WeightPeptidesProtein StabilityReproducibility of ResultsImmunologic FactorsPeptides

Identifiers

PMID32322594
PMCPMC7154977
OpenAlexW3015065859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.